Menu

Markets

Research

News

Learn
Paper trading
AI Chat
Get the app WatchlistsPortfoliosAlerts
Sign in

iTeos Therapeutics, Inc. ITOS

Full chart Compare
Set alert

Price alert · ITOS

All alert types
10.15 0.00 (+0.00%)

At closeAug 29, 2025, 4:00 PM EDT

10.15 Day range 10.15

52-week range unavailable

YTD
+32.16%
1 year
-40.82%

Financial health

Altman Z-Score

1.65 Distress zone

Bankruptcy-risk model: below 1.81 distress, above 2.99 safe.

Piotroski F-Score

1 / 9 Weak

Nine pass/fail tests of profitability, leverage and efficiency.

Valuation

P/E -2.3×
FY 2018: -7.9×FY 2019: -8.4×FY 2020: -27.3×FY 2021: 7.6×FY 2022: 7.2×FY 2023: -3.5×FY 2024: -2.3×
FY 2018 5y median -2.3× FY 2024
P/S 8.9×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 4.8×FY 2022: 2.6×FY 2023: 31.1×FY 2024: 8.9×
FY 2018 5y median 4.8× FY 2024
P/B 0.5×
FY 2018: 9.5×FY 2019: 12.1×FY 2020: 3.7×FY 2021: 3.0×FY 2022: 1.0×FY 2023: 0.7×FY 2024: 0.5×
FY 2018 5y median 1.0× FY 2024
P/FCF -3.1×
FY 2018: -7.4×FY 2019: -7.9×FY 2020: -46.4×FY 2021: 3.2×FY 2022: -6.2×FY 2023: -3.7×FY 2024: -3.1×
FY 2018 5y median -3.7× FY 2024
EV/EBITDA -1.4×
FY 2018: -7.3×FY 2019: -7.7×FY 2020: -22.4×FY 2021: 3.1×FY 2022: 2.8×FY 2023: -1.3×FY 2024: -1.4×
FY 2018 5y median -1.3× FY 2024
EV/Sales 5.0×
FY 2018: 0.0×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 2.3×FY 2022: 1.5×FY 2023: 11.6×FY 2024: 5.0×
FY 2018 5y median 2.3× FY 2024
FCF Yield -32.1%
FY 2018: -13.5%FY 2019: -12.6%FY 2020: -2.2%FY 2021: 31.3%FY 2022: -16.1%FY 2023: -27.3%FY 2024: -32.1%
FY 2018 5y median -16.1% FY 2024

Profitability

Gross Margin 96.5%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 99.8%FY 2022: 99.7%FY 2023: 92.9%FY 2024: 96.5%
FY 2018 5y median 96.5% FY 2024
Operating Margin -455.8%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 71.0%FY 2022: 47.2%FY 2023: -1199.7%FY 2024: -455.8%
FY 2018 5y median 0.0% FY 2024
Net Margin -384.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 62.2%FY 2022: 36.1%FY 2023: -894.3%FY 2024: -384.0%
FY 2018 5y median 0.0% FY 2024
ROE -22.8%
FY 2018: -120.0%FY 2019: -143.3%FY 2020: -11.8%FY 2021: 38.8%FY 2022: 14.6%FY 2023: -19.6%FY 2024: -22.8%
FY 2018 5y median -11.8% FY 2024
ROIC -24.6%
FY 2018: -96.1%FY 2019: -159.8%FY 2020: -13.7%FY 2021: 35.2%FY 2022: 11.5%FY 2023: -24.0%FY 2024: -24.6%
FY 2018 5y median -13.7% FY 2024
ROA -19.6%
FY 2018: -65.9%FY 2019: -73.0%FY 2020: -11.0%FY 2021: 24.2%FY 2022: 12.8%FY 2023: -16.9%FY 2024: -19.6%
FY 2018 5y median -11.0% FY 2024

Growth (YoY)

Revenue 177.9%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: -22.4%FY 2023: -95.3%FY 2024: 177.9%
FY 2018 FY 2024
Operating Income -5.6%
FY 2018: 0.0%FY 2019: -30.4%FY 2020: -61.3%FY 2021: 641.3%FY 2022: -48.4%FY 2023: -219.6%FY 2024: -5.6%
FY 2018 FY 2024
EPS (diluted) -5.4%
FY 2018: 0.0%FY 2019: 5.4%FY 2020: 45.4%FY 2021: 558.1%FY 2022: -54.9%FY 2023: -223.0%FY 2024: -5.4%
FY 2018 FY 2024
Free Cash Flow 6.5%
FY 2018: 0.0%FY 2019: -23.5%FY 2020: -7.0%FY 2021: 2105.2%FY 2022: -121.9%FY 2023: 4.8%FY 2024: 6.5%
FY 2018 FY 2024

Financial Health

Current Ratio 12.6×
FY 2018: 4.7×FY 2019: 2.0×FY 2020: 22.6×FY 2021: 2.9×FY 2022: 15.0×FY 2023: 13.8×FY 2024: 12.6×
FY 2018 5y median 13.8× FY 2024
Quick Ratio 12.6×
FY 2018: 4.7×FY 2019: 2.0×FY 2020: 22.7×FY 2021: 2.9×FY 2022: 15.0×FY 2023: 13.8×FY 2024: 12.6×
FY 2018 5y median 13.8× FY 2024
Debt / Equity 0.0×
FY 2018: 0.4×FY 2019: 0.3×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2018 5y median 0.0× FY 2024
Net Debt / EBITDA 1.1×
FY 2018: 0.9×FY 2019: 0.6×FY 2020: 8.9×FY 2021: -3.3×FY 2022: -1.9×FY 2023: 2.2×FY 2024: 1.1×
FY 2018 5y median 1.1× FY 2024
Interest Coverage 0.0×
FY 2018: -326×FY 2019: 0.0×FY 2020: 0.0×FY 2021: 0.0×FY 2022: 0.0×FY 2023: 0.0×FY 2024: 0.0×
FY 2018 5y median 0.0× FY 2024

Dividends

Dividend Yield 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024
Payout Ratio 0.0%
FY 2018: 0.0%FY 2019: 0.0%FY 2020: 0.0%FY 2021: 0.0%FY 2022: 0.0%FY 2023: 0.0%FY 2024: 0.0%
FY 2018 5y median 0.0% FY 2024

Annual · latest fiscal year ends 2024-12-31